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Primary tumors of the colorectal cancers are assessed pathologically based on the tumor
spread into the bowel wall. The assessment of serosal involvement, which may be rel-
evant to pT4, can be challenging for pathologists, making the consistency of diagnoses
questionable. As solutions to this problem, the following two strategies could be adopted.
One would be to use special staining or immunohistochemical staining techniques for diag-
nostic assistance. The other would be to construct recommendations for the assessment
of tumor spreading and to obtain a world-wide consensus on the criteria used to assess
tumor spreading. Using elastic staining, we previously reported that peritoneal elastic lami-
nal invasion (ELI) could be objectively determined and would likely contribute to a simplified
and more objective stratification of deep tumor invasion around the peritoneal surface. We
also noted the importance of sampling, staining, and histo-anatomical knowledge in the
application of elastic staining during routine pathological diagnosis. Here we review the
history of primary tumor stratification leading to the present TNM classification and report
on the current status of pathological assessments made at our hospital to summarize what
has been established and what is further required for the pathological diagnosis of tumor
spreading in patients with colorectal cancer.
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INTRODUCTION
Since the first categorization efforts reported by Lockhart-
Mummery (1926–1927), primary colorectal cancers have been
consistently stratified based on the extent of their spreading into
the bowel wall (Dukes, 1932; Jass et al., 1987; Newland et al.,
1995). Deep tumor invasion around the peritoneal surface has
also been reported as a prognostic factor (invasion through all
the layers, peritoneal involvement, or direct spreading involv-
ing a free serosal surface; Astler and Coller, 1954; Shepherd
et al., 1997). These reports were base for the 7th TNM clas-
sification (Sobin et al., 2009). Reviewing these reports should
help to renew our understanding of what has been established
and what is further required for the pathological diagnosis of
tumor spreading. Using elastica staining, we previously showed
that peritoneal elastic laminal invasion (ELI) could be objec-
tively determined and would likely contribute to a simplified
and more objective stratification of deep tumor invasion around
the peritoneal surface (Kojima et al., 2010). We also note the
importance of sampling, staining, and histo-anatomical knowl-
edge to apply elastica staining to routine pathological diagno-
sis. In this review, we will reflect on the brilliant achievements
in the assessment of tumor spreading in colorectal cancer. We
will also report on the current status of pathological assess-
ments made at our hospital and will expose associated prob-
lems that will require solutions in the future. In addition to
the diagnostic criteria, we also feel that a comprehensive min-
imum consensus is required for pathology protocols, including
sampling and staining protocols in the future. Next, in addition to
their prognostic relevance, areas with ELI exhibit marked fibro-
sis and tumor budding. These findings suggest that ELI areas
may actively induce metastasis and such observations may lead
to future biological investigations. On the other hand, ELI can
only be a surrogate marker of deep tumor invasion. Therefore,
we reviewed our records and showed that ELI was a superior
prognostic marker compared with the depth of tumor invasion,
suggesting that the ELI tumor area may play an active role in
the metastasis of colorectal cancer. Finally, we summarize sev-
eral biological topics that may be relevant to our pathological
findings.
HISTORY OF THE ASSESSMENT OF TUMOR SPREADING IN
COLORECTAL CANCER
Many early reports of the classification of tumor spreading focused
mainly on rectal cancer. In the first report by Lochart-Mummery,
tumor spreading and metastasis was classified as follows: (A)
favorable cases, tumor did not invade the muscularis; no nodes
involved; (B) medium cases, tumor invaded muscular coat; no
extensive involvement of nodes; and (C) very bad cases, tumor
large, and fixed; or extensive involvement of nodes. In the classi-
cal Duke’s classification, tumor spreading was classified according
to the presence of extra-rectal tissue. And in the modified Duke’s
classification published in 1958, tumor spreading was classified
as (1) confined to the bowel wall, (2) commencing to invade the
extra-rectal tissues, (3) well established in the mesentery, or (4)
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deeply invasive, possibly into neighboring organs. Also, in the
modified Duke’s classification reported by Kirklin et al. (1949)
divided as follows: type A, lesion limited to the mucosa; Type
B1, lesion extended into the muscularis propria, but not pen-
etrating it; Type B2, lesion penetrated through the muscularis
propria. They completed the construction of an outline for the
current pT1-3 stages in the current TNM classification. They
also found that the extent of local spreading was associated with
a poor 5 year survival rate, and their report was followed by
studies measuring the depth of local spreading in rectal cancer
(Cawthorn et al., 1990; Shirouzu et al., 2011). As reported by
Kirklin et al. we now know that most of these classifications can
also be used for the assessment of colon cancer. On the other
hand, some histo-anatomical differences exists, the largest is the
existence of the peritoneal coat, leading to differences in the patho-
logical criteria for pT4 colon cancer, compared with those used
for rectal cancer. Free mesothelial surface involvement or local
peritoneal involvement (lPI), which relevant to present pT4 was
reported by Newland et al. (1993) and Shepherd et al., 1995; Lude-
man and Shepherd, 2005). They challenged to sub-stage tumor
spreading beyond the bowel wall using the peritoneal surface.
Using the modified Australian ClinicoPathological Staging System
(ACPS), Newland et al. showed that tumor spreading involving a
free mesothelial surface was a prognostic factor. Shepherd et al.
showed that LPI Group 3 and 4 were predictors of a poor prog-
nosis in patients with colorectal cancer. Apart from the details
of these definitions, they found colorectal cancer spreading just
around or over the outer surface of the bowel wall was associated
with a poor prognosis, and many data support their criteria (we
termed “tumor involvement of free mesothelial surface,” “pT4,”
and “LPI Group 3 and 4” as serosal involvement in following
context). Using a fully standardized pathology, other strategies
for the treatment of colorectal cancer may be developed (Wolpin
and Mayer, 2008). For example, adjuvant chemotherapy may pro-
vide a benefit to colonic cancer patients with serosal involvement
who do not have lymph node metastasis (stage IIB; Morris et al.,
2007).
CURRENT STATUS OF MACROSCOPIC AND HISTOLOGICAL
EXAMINATION TO ASSESS SEROSAL INVOLVEMENT AND
EXPOSURE OF DIAGNOSTIC PROBLEMS
Detailed macroscopic observation and sampling are essential steps
in making an accurate and objective diagnosis. Macroscopic fea-
tures from luminal and serosal side were shown in Figures 1A,C,
respectively. The slices we made are shown in black line in
Figures 1B,D. In our department, surgically resected specimens
are extended using a pin and cork board. After 24 h of fixation in
10% buffered formalin, macroscopic observations of the lumi-
nal, and serosal sides are performed, and the deepest area of
the ulcer floor and indentations of the serosal surface are iden-
tified. In the tenial area of the colonic wall, serosal indentation is
easy to identify (Figure 1D, arrow). On the other hand, serosal
involvement on the adipose rich mesenteric side is often difficult
to identify (Figure 1D, arrow head). In the normal state, fatty
appendices of the colon form peritoneum-lined crevice. Serosal
involvement, especially free-floating tumor cells are often found
in this area. Macroscopically, the existence of serosal involvement
in this area can be speculated based on widening or brown-
ish change in the crevice near the deepest area of ulcer floor
(Figure 1D, arrow head). Therefore, we make the first cross-
sectioning of the tumor in a manner that places the cut through
these above-mentioned areas (Figures 1B,D). A parallel slice is
then made after the first slice. Indentations of the serosal surface
should be identified on the cut surface and sampled extensively
(Figure 1E, arrow and arrow head). In addition, case with serosal
involvement frequently shows macroscopic stricture (Miyamoto
et al., 2001). Serosal involvement can also be observed as a
macroscopic streak sign on the cut surface, providing a useful
clue for identification (Inomata et al., 1998; Figure 1E, arrow
head).
Histologically, many pathologists report tumor spreading
according to the definition in TNM classification. However, a
recent study has questioned the reproducibility of serosal involve-
ment. Similarly, the diagnosis of pT3 or pT4 is often difficult. This
situation has been well described by Stewart et al. (2007b, 2011).
They pointed out the histo-anatomical and histopathological char-
acteristics of peritoneal tissue. Histo-anatomically, peritoneal tis-
sue consists of the mesothelium and submesothelial layer, which
coats the colonic wall and the surrounding pericolic adipose tis-
sue (Mills, 2007). Therefore, especially around the adipose tissue,
the peritoneal surface is not smooth, but instead exhibits peri-
toneal clefts or peritoneal reflection where serosal involvement is
frequently seen (Figure 1C).
Difference in the level of H.E slides and the difference of
the elastic staining used can influence on the diagnosis of both
serosal invasion and ELI. In our hospital, histological evalua-
tion is performed by two levels of H.E staining and one rou-
tine Elastica staining using Maeda Resorcin-Fuchshin Solution as
described previously (Kojima et al., 2011). Histological slides of the
same tumor section with Figure 1E was shown in Figures 2A–F.
Arrow and arrow head in Figure 1E are concordant with that
in Figures 2A,B. High power magnification of arrow is cor-
responded to Figures 2C,D. And that of arrow head is corre-
sponded to Figures 2E,F. We want to stress that histological
deepest area of tumor invasion is concordant with macroscopic
indentation. Furthermore, peritoneal elastic lamina is retracting
toward the tumor (Figures 2B,D,F). Histopathologically, although
the normal submesothelial layer contains few cells, this tissue
frequently shows fibro inflammatory changes when tumor cells
invade areas near this tissue (Figure 2C). In colorectal cancer,
fibroinflammation is often seen near the invasive front, but this
phenomenon is much more prominent in the tumor area with
ELI (Figure 2C). When the fibrosis is prominent, a peritoneal
surface elevation toward the tumor is often seen (Figure 2A,
arrow). In some cases, prominent fibrosis with a non-cellular
matrix component forms a fibrotic focus (Nishimura et al., 1998;
Figure 2G). This characteristic morphological features also often
found in the tumor area with ELI (Figure 2H). Using low-
power observations, a scar-like radiating fibrosclerotic core is
observed (Van den Eynden et al., 2007; Figures 3A,B). Using
high power magnification, the fibroblasts arranged in a storiform
pattern (Figures 3C,D). Marked collagenization is also found.
The tumor cell clusters become sparser within area of fibrosis,
and budding foci are often seen within this area (Figure 3D).
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FIGURE 1 | Macroscopic assessment of serosal invasion in colonic
cancer. Macroscopic features from luminal side (A,B), serosal side (C,D), and
cut surface of the lesion (E). In this case, we identified both a serosal
indentation (arrow) and the widening and brownish change of the crevice
(arrow head) in (D). The first two slices through these lesions are shown in
(B,D), and the cut surface is shown in (E). On the cut surface, the indentation
of the serosal surface (arrow) and a streak sign (arrow head) were identified.
These areas were sampled for histological examination in Figure 2.
Inflammatory cells, including macrophages, are often seen around
these lesions. CD68-positive or CD204-positive macrophages are
found predominantly around the peritoneal elastic lamina and
fibrotic focus (Figures 3E,F). Such a variety of histopathologi-
cal alterations makes it difficult to determine serosal involvement
by H.E stain alone. Accordingly, even with optimized sampling,
the frequency of serosal invasion varies in reports, and the diag-
nostic concordance is relatively low (Compton, 2003). Therefore,
consistent data regarding tumor spreading as assessed at differ-
ent hospitals is impossible, and this fact hinders the design of
multicenter therapeutic trials for high risk stage II colon can-
cer patients. To overcome this situation, two approaches can be
considered. One approach is to establish more detailed diagnos-
tic criteria. Recommendations including assessment and sample
preparation protocols may also be useful. In fact, extensive sam-
pling using detailed macroscopic observations definitely improves
the accuracy of diagnoses of serosal involvement (Ludeman and
Shepherd, 2005). The other approach is to use special staining or
immunohistochemical staining techniques to provide diagnostic
assistance.
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FIGURE 2 | Histological features of serosal invasion in the case shown
in Figure 1. The arrows and arrow heads in the macroscopic picture
shown in Figure 1E are identical to the arrows and arrow heads in the
histologic picture shown in (A,B). Elastica staining picture from the serial
section was obtained, and H.E stained (A,C,E,G) is same area with elastic
stained (B,D,F,H), respectively. (A–F) Histological features showing
peritoneal surface elevation toward the tumor (arrow) and a streak sign
(arrow head) in a colorectal cancer specimen. The tumor had deeply
invaded the region near the serosal surface, and prominent
fibroinflammation was visible in the area, identical to the macroscopic
findings (C,E). ELI is also seen in the area with macroscopic findings (D,F).
In some cases, prominent fibrosis with a non-cellular matrix component
forms a fibrotic focus (G). Using elastica staining we detect fibrotic focus
just beneath the peritoneal elastic lamina (H).
WAYS TO CONSTRUCT STANDARDIZED ASSESSMENTS OF
SEROSAL INVOLVEMENT TO OVERCOME CURRENT
DIAGNOSTIC PROBLEMS
ESTABLISHMENT OF STANDARDIZED CRITERIA
Pathologists must regularly make difficult choices to diagnose
serosal invasion. Diagnostic recommendations or criteria may
lessen such difficulties and may even improve the concordance of
pathological diagnoses. Any group may decide to establish criteria
(informal approach). On the other hand, a criteria established
based on more structural surveys would be acceptable for many
pathologists, and are increasingly being used to develop clinical
guidelines. Klimstra et al. (2010) used this structural survey of
“Delphi method” to establish a consensus regarding the reporting
of neuroendocrine tumors. Such a method may also contribute
to establishing consensus-based criteria for pathological serosal
invasion.
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FIGURE 3 | Association of ELI, fibrotic focus, and macrophage. A scar like
radiating fibrosclerotic core of a fibrotic focus [(A), black arrow head] is found
just beneath the peritoneal elastic lamina [(B), white arrow head]. Using
high-power magnification, the fibroblasts arranged in a storiform pattern (C,D)
The distribution of CD204-positive macrophages and an association with the
ELI and fibrotic focus is seen in (E,F). CD204-positive macrophages are
distributed along the periphery of the fibrotic focus (E) and along the
peritoneal elastic lamina (F).
DIAGNOSTIC ASSISTANCE OF ASSESSING SEROSAL INVASION USING
ELASTICA STAINING: ELASTIC LAMINAL INVASION OF COLON CANCER
Special staining and immunohistochemical staining techniques
may also be useful for making objective diagnoses of serosal
involvement. The peritoneal elastic lamina lies just beneath the
subserosal layer. This structure can be visualized using elastica
stainings or elastin immunostaining. Although tumor invasion
beyond the peritoneal elastic lamina (also known as ELI) is not
equal to serosal involvement, based on the position, the presence
of deep invasion near the peritoneal surface can be estimated.
Recently, the diagnostic utility of ELI as a prognostic marker has
been reported. Shinto et al. (2004) firstly reported the utility of
ELI for determining high risk patients with pT3 colorectal can-
cers. They found that pT3 colorectal cancers with ELI (which they
termed “pT3 deep”) had similar clinical outcomes to patients with
pT4 tumors. Their data was confirmed in our series. On the other
hand, the peritoneal elastic lamina is anatomically, the deepest
structure from muscular layer. Therefore ELI can only be regarded
as a surrogate marker for deep tumor invasion. In this review,
we analyzed our previously reported record of 304 patients with
curatively resected Stage II or III colonic cancers (Kojima et al.,
2010). Using a concordance probability, we evaluated the discrim-
inatory power of ELI for over-all survival and compared that of the
depth of tumor invasion. The depth of tumor invasion was mea-
sured from the outer border of the muscular layer (Shirouzu et al.,
2011). As shown in Table 1, although the concordance probability
of ELI was slightly lower than that for the lymph node metastasis,
it was much larger than that for the depth of invasion. There-
fore, we showed that ELI itself has at least diagnostic utility with
more strong predictive power of over-all survival than the depth
of tumor invasion. Rather, based on the histological features men-
tioned above, we estimated that the ELI microenvironment may be
capable of promoting tumor progression. Elastin immunostaining
was reported not to be more sensitive than elastica staining
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Table 1 | Estimated concordance probability.
Variables Concordance probability SE
Elastic laminal invasion 0.6038 0.0272
Depth of tumor invasion 0.5510 0.0274
Lymph node metastasis 0.6117 0.0276
(Stewart et al., 2007a). Elastica staining is relatively inexpensive
and stable method. The detailed examination of vascular inva-
sion is also possible. Therefore this special staining technique can
be used as a routine staining method (Abdulkader et al., 2006).
Similar to lung cancer, cases with ELI can be classified as dif-
ferent pT entities (Puppa et al., 2011). On the other hand, the
peritoneal elastic lamina does not completely cover the colonic
wall. The thickness of the elastic lamina also differs depending on
the anatomical site (Knudsen, 1991). This fact prompted us, in
our previous study, to identify the delicate elastic lamina clearly
by following it from one area to another using multiple elastica
stainings. And this method made us possible to follow delicate
elastic lamina. However, our method may not be practical. And
peritoneal elastic lamina may not be detected in more cases in
the routine practice (Canney et al., 2012). Furthermore, the stain-
ing method used for elastica staining and the number of sections
that are stained have not been standardized. We are not yet sure
how many slides with elastica staining are needed for a consistent
ELI diagnosis. Standard recommendations for the assessment of
ELI and serosal invasion are needed for consistent pathological
classification.
FUTURE PERSPECTIVES AND HYPOTHESES
HISTOLOGICAL FEATURE OF ELI MAY LEAD TO BIOLOGICAL CONCEPTS
INVOLVING THE CANCER MICROENVIRONMENT
Pathologists can make hypothesis based on histological findings.
The presently reported histological features of the ELI area of the
tumor may stimulate the imagination of pathologists, possibly
leading to medical innovations. Based on our histological find-
ings of fibroinflammation and tumor budding, new hypotheses
are likely to be formulated.
FIBROINFLAMMATION AND THE MICROENVIRONMENT OF THE ELI
TUMOR AREA
In addition to the histological features of fibroinflammation in
the ELI area, we showed that ELI is strongly associated with
distant metastasis, statistically. We have speculated that cancer
cells perforate the visceral peritoneum, inducing peritoneal dis-
semination. However, based on our findings, we speculated that
the subserosal microenvironment may provide a special means
of actively inducing tumor metastasis. We have found a few
previous reports that may available for proving our hypothe-
sis. First, colonic subserosal or other subperitoneal fibroblasts
have been cultured in vitro. These fibroblasts reportedly pro-
duce MCP-1 and VEGF in response to some biological stimuli,
such as TGF-beta, IL-1beta, and TNF-alpha, or in response to
physiological stimulation such as hypoxia (Witowski et al., 2001;
Hirahara et al., 2004; Osada et al., 2009). We speculated that
these features of subserosal fibroblast may be associated with
the promotion of tumor metastasis in patients with colon can-
cer. Enhanced reactivity in response to stimuli may be associated
with macroscopic indentation or histological fibrosis, and subse-
quently cancer metastasis. We would like to stress that despite the
above-mentioned pathological and biological data, study on the
interaction between cancer cells and peritoneal fibroblasts are very
rare.
BIOLOGICAL TOPICS INCLUDING THE TUMOR MICROENVIRONMENT,
CANCER STEM CELLS, AND EMT, THAT MAY BE RELEVANT TO OUR
PATHOLOGICAL FINDINGS
We often see tumor budding foci in the ELI area. The microen-
vironment of ELI can be enriched by chemokines, cytokines, or
growth factors, which may induce morphological alterations of the
tumor cells (Klampfer, 2011). Budding cells have been reported to
share a common phenotype with cancer stem cells or the epithelial
mesenchymal transition (Brabletz et al., 2005; Kalluri and Wein-
berg, 2009). Both concepts are largely biological and we are not
sure whether these biological concepts can be accurately compared
with pathological morphological concepts, even using the expres-
sions of cancer stem cells or EMT markers (Kojima et al., 2008).
However, we now know that budding cells are enriched in the ELI.
Therefore, by investigating reciprocal interactions between cancer
cells and subserosal fibroblasts, we may be able to estimate the ELI
microenvironment and the relevance between tumor budding and
the EMT or cancer stem cells.
CONCLUDING REMARKS
We have reflected on the pathological history, examined the cur-
rent status and problems, and provided future perspectives based
on presently available data. We wish to mention that our current
clinicopathological works have been supported by the brilliant
work of many of our senior pathologists. We believe that an accu-
rate review and recognition of this history will lead to further
pathological and biological works for cancer patients.
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